Screening for hereditary angioedema (HAE) at 13 emergency centers in Osaka, Japan: A prospective observational study

    loading  Checking for direct PDF access through Ovid

Abstract

Hereditary angioedema (HAE) with deficiency of C1 inhibitor (C1-INH) is an autosomal-dominant disease characterized by recurrent episodes of potentially life-threatening angioedema. The objective is to study the incidence of HAE among patients who visit the emergency department.

This was a 3-year prospective observational screening study involving 13 urban tertiary emergency centers in Osaka prefecture, Japan. Patients were included if they met the following criteria: unexplained edema of the body, upper airway obstruction accompanied by edema, anaphylaxis, acute abdomen with intestinal edema (including ileus and acute pancreatitis), or asthma attack. C1-INH activity and C4 level were measured at the time of emergency department admission during the period between July 2011 and June 2014.

This study comprised 66 patients with a median age of 54.0 (IQR: 37.5–68.3) years. Three patients were newly diagnosed as having HAE, and 1 patient had already been diagnosed as having HAE. C1-INH activity levels of the patients with HAE were below the detection limit (<25%), whereas those of non-HAE patients (n = 62) were 106% (IQR: 85.5%–127.0%) (normal range, 70%–130%). The median level of C4 was significantly lower in the patients with HAE compared with those without HAE (1.2 [IQR: 1–3] mg/dL vs 22 [IQR: 16.5–29.5] mg/dL, P < 0.01) (normal range, 17–45 mg/dL).

Three patients with undiagnosed HAE were diagnosed as having HAE in the emergency department during the 3-year period. If patients have signs and symptoms suspicious of HAE, the levels of C1-INH activity and C4 should be measured.

Related Topics

    loading  Loading Related Articles